Kristen N. Balogh - Concepedia

Concepedia

Author

Kristen N. Balogh

BioNTech (United States)ORCID

Also Known As

K BALOGH, Kristen Balogh, Kristen N. Balogh

22

Publications

1.1K

Citations

7

H-Index

21

Concepts

All Affiliations

BioNTech (United States)Dana-Farber Cancer Institute Dana-Farber Brigham Cancer Center Harvard University University of California, Los Angeles

KN

About

Kristen N. Balogh is an author at BioNTech (United States) specializing in medicine, tumor microenvironment, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	1.1K
2	Immunology	4	4	365
3	Immunotherapy	4	4	365
4	Cell Biology	2	2	120
5	Cancer Therapeutics	2	2	899

Kristen N. Balogh

×

6

Publications

1.1K

Citations

6

H-Index

	Year	Citations
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer Patrick A. Ott, Siwen Hu‐Lieskovan, Bartosz Chmielowski, Cell UrologyMedicinePhase Ib TrialImmune Checkpoint InhibitorCancer Treatment	2020	699
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer Mark M. Awad, Ramaswamy Govindan, Kristen N. Balogh, Cancer Cell MedicineImmunologyTherapeutic VaccineBronchial NeoplasmImmune Checkpoint Inhibitor	2022	200
Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses Kristen N. Balogh, Dennis J. Templeton, Janet V. Cross PLoS ONE T-regulatory CellImmunologyCell DeathImmunologic MechanismImmunotherapy	2018	104
Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1 Asaf Poran, Julian Scherer, Meghan E. Bushway, Cell Reports Medicine Tcr RepertoiresImmunologyImmune Cell TherapyT CellsImmunotherapy	2020	45
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial Jessica S.W. Borgers, Divya Lenkala, Victoria Kohler, Nature Medicine	2025	32
Myeloid Derived Suppressor Cells Migrate in Response to Flow and Lymphatic Endothelial Cell Interaction in the Breast Tumor Microenvironment LaDeidra Monét Roberts, Matthew J. Perez, Kristen N. Balogh, Cancers Breast OncologyImmunologyBiological MicroenvironmentsImmunoeditingImmunotherapy	2022	16

Page 1